Further, there are MMR gene-dependent differences regarding the risk of colorectal adenomas and carcinomas, and regarding somatic mutations in patients with Lynch syndrome [25] which supports the need of adjusting surveillance guidelines based on MMR gene variants. Here, MRC1 is linked to colorectal adenoma.